CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 900 enrolled
Drug / intervention
early dischargeprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01860079
NCT01860079N/ACompleted

Early Discharge After Primary Percutaneous Coronary Intervention: A Prospective Randomized Multi-center Trial (the EDAP PCI Trial)

Acibadem University·interventional·Posted May 22, 2013·Updated Apr 7, 2016

In Brief

A clinical study evaluating early discharge for ST Elevation Myocardial Infarction. Completed, enrolled 900 participants across 3 sites.

Detailed Summary

* When Primary percutaneous coronary intervention (PPCI) is performed expeditiously and at a high-volume centre, it is the optimal approach for ST elevation myocardial infarction (STEMI) . In contrast to the clarity of how to treat STEMI, there is no clear definition for when to discharge and which patient to discharge. * An early discharge strategy may be desired by all parties (financial health care provider, treating physician, nurse, patient, patient's relatives)involved in STEMI. * The main goal in our study is to test the hypothesis that an early discharge strategy within 48-56 hours in patients with successful PPCI is as safe as in those patients who stay longer (96-120 hours) as of a standard procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 22, 2013
Enrollment StartMay 1, 2013
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 13.1 years ago

Interventions

early dischargeprocedure

In the early discharge group, patients are actively targeted for hospital discharge within 48-56 hours.